1. Home
  2. TENX vs XHLD Comparison

TENX vs XHLD Comparison

Compare TENX & XHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • XHLD
  • Stock Information
  • Founded
  • TENX 1967
  • XHLD 2011
  • Country
  • TENX United States
  • XHLD United States
  • Employees
  • TENX N/A
  • XHLD N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • XHLD
  • Sector
  • TENX Health Care
  • XHLD
  • Exchange
  • TENX Nasdaq
  • XHLD NYSE
  • Market Cap
  • TENX 21.6M
  • XHLD 17.6M
  • IPO Year
  • TENX N/A
  • XHLD 2025
  • Fundamental
  • Price
  • TENX $5.90
  • XHLD $0.35
  • Analyst Decision
  • TENX Strong Buy
  • XHLD Strong Buy
  • Analyst Count
  • TENX 3
  • XHLD 1
  • Target Price
  • TENX $16.00
  • XHLD $8.00
  • AVG Volume (30 Days)
  • TENX 40.6K
  • XHLD 950.2K
  • Earning Date
  • TENX 08-12-2025
  • XHLD 08-20-2025
  • Dividend Yield
  • TENX N/A
  • XHLD N/A
  • EPS Growth
  • TENX N/A
  • XHLD N/A
  • EPS
  • TENX N/A
  • XHLD N/A
  • Revenue
  • TENX N/A
  • XHLD $3,115,000.00
  • Revenue This Year
  • TENX N/A
  • XHLD $42.64
  • Revenue Next Year
  • TENX N/A
  • XHLD $65.31
  • P/E Ratio
  • TENX N/A
  • XHLD N/A
  • Revenue Growth
  • TENX N/A
  • XHLD N/A
  • 52 Week Low
  • TENX $2.80
  • XHLD $0.33
  • 52 Week High
  • TENX $7.89
  • XHLD $8.54
  • Technical
  • Relative Strength Index (RSI)
  • TENX 53.10
  • XHLD N/A
  • Support Level
  • TENX $5.77
  • XHLD N/A
  • Resistance Level
  • TENX $5.96
  • XHLD N/A
  • Average True Range (ATR)
  • TENX 0.32
  • XHLD 0.00
  • MACD
  • TENX 0.01
  • XHLD 0.00
  • Stochastic Oscillator
  • TENX 26.98
  • XHLD 0.00

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About XHLD TEN HOLDINGS INC

TEN Holdings Inc is a provider of event planning, production, and broadcasting services. The company produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by its Xyvid Pro Platform. Physical events involve live streaming and video recording of physical events. The Company operates business as one operating segment which includes two revenue types: Hybrid and Virtual Events and Physical Events.

Share on Social Networks: